Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xmark Funds is a specialized investment firm focused on the healthcare and life sciences sectors. The firm provides growth capital and strategic financing to biotechnology, medical device, and pharmaceutical companies, often through structured private investments in public equity (PIPEs) and private equity transactions. Xmark is recognized for its expertise in identifying undervalued small-to-mid-cap companies with innovative technologies or therapeutic candidates. By leveraging deep industry knowledge, the firm aims to support the development and commercialization of medical advancements that address significant unmet clinical needs. Its investment strategy typically involves a hands-on approach to help portfolio companies navigate clinical and regulatory milestones.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xmark Funds.